Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [615]
News [1043]
Articles [54]
Editorials [2]
Conferences [96]
elearning [5]
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition
Dr Terry Mamounas - UF Health Center, Orlando, USA
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition ( Dr Terry Mamounas - UF Health Center, Orlando, USA )
7 Dec 2016
Experts discuss the latest in prostate cancer treatments and strategies
Dr Elena Verzoni, Prof Pablo José Maroto-Rey, Dr Elzbieta Senkus-Konefka, Dr...
Experts discuss the latest in prostate cancer treatments and strategies ( Dr Elena Verzoni, Prof Pablo José Maroto-Rey, Dr Elzbieta Senkus-Konefka, Dr Simon Crabb )
20 Nov 2016
CDK clinical trial results, benefit, side effects and costs
Dr Pierfranco Conte - Instituto Oncologico Veneto, Padua, Italy
CDK clinical trial results, benefit, side effects and costs ( Dr Pierfranco Conte - Instituto Oncologico Veneto, Padua, Italy )
26 Oct 2016
Biomarkers of sensitivity and resistance
Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Biomarkers of sensitivity and resistance ( Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
26 Oct 2016
CDK4/6 inhibition: PALOMA2 versus MONALEESA2
Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria
CDK4/6 inhibition: PALOMA2 versus MONALEESA2 ( Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )
17 Oct 2016
LUME study of nintedanib finds improved PFS, but no overall survival boost
Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium
LUME study of nintedanib finds improved PFS, but no overall survival boost ( Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium )
12 Oct 2016
Monitoring patterns of care in mCRPC patients with the help of the Cancer...
Dr Simon Chowdhury - Guy's Hospital, London, UK
Monitoring patterns of care in mCRPC patients with the help of the Cancer Registry ( Dr Simon Chowdhury - Guy's Hospital, London, UK )
10 Oct 2016
Lurbinectedin in BRCA 1/2 breast cancer
Dr Judith Balmaña - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Lurbinectedin in BRCA 1/2 breast cancer ( Dr Judith Balmaña - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016
Highlights of ESMO 2016
Dr Andrés Cervantes - ESMO 2016 Scientific Chair
Highlights of ESMO 2016 ( Dr Andrés Cervantes - ESMO 2016 Scientific Chair )
10 Oct 2016
FALCON trial: fulvestrant vs. anastrozole for HR advanced breast cancer
Prof John Robertson - University of Nottingham, Nottingham, UK
FALCON trial: fulvestrant vs. anastrozole for HR advanced breast cancer ( Prof John Robertson - University of Nottingham, Nottingham, UK )
8 Oct 2016
Fulvestrant in FALCON trial improves PFS in advanced breast cancer
Dr Matthew Ellis - Washington University in St Louis, USA
Fulvestrant in FALCON trial improves PFS in advanced breast cancer ( Dr Matthew Ellis - Washington University in St Louis, USA )
8 Oct 2016
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?
Prof Michael Seckl - Imperial College London, London
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer? ( Prof Michael Seckl - Imperial College London, London )
17 Jul 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation